Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Nicholson

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2014
Solid tumors of childhood display specific serum microRNA profilesMatthew J Murray, Katie L Raby, Harpreet K Saini, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 20, 2017
"Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical TrialsMatthew J Murray, Hannah L Watson, Dawn Ward, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|December 15, 2023
Wilms Tumor With Raised Serum Alpha-Fetoprotein: Highlighting the Need for Novel Circulating BiomarkersRebecca Green, Adeeb Ahmed, Ben Fleming, et al.
Neuro-Oncology Advances|July 10, 2020
Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumorsMatthew J Murray, Thankamma Ajithkumar, Fiona Harris, et al.
British Journal of Cancer|November 3, 2023
Correction: Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruptionShivani Bailey, Marta Ferraresso, Luz Alonso-Crisostomo, et al.
British Journal of Cancer|October 3, 2023
Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruptionShivani Bailey, Marta Ferraresso, Luz Alonso-Crisostomo, et al.
British Journal of Cancer|December 17, 2015
A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumoursMatthew J Murray, Emma Bell, Katie L Raby, et al.
Andrology|October 18, 2022
Small non-coding RNA sequencing reveals global dysregulation of piwi-interacting RNA (piRNA) expression in gonadal malignant germ cell tumoursSean Laidlaw, Luz Alonso-Crisostomo, Shivani Bailey, et al.
Neuro-Oncology|February 26, 2022
Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trialsAdriana Fonseca, Cecile Faure-Conter, Matthew J Murray, et al.
Frontiers in Oncology|July 30, 2024
Acute toxicity of chemotherapy in central nervous system germ cell tumour patients according to ageGilles Palenzuela, Camille Schiffler, Didier Frappaz, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2014
Solid tumors of childhood display specific serum microRNA profilesMatthew J Murray, Katie L Raby, Harpreet K Saini, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 20, 2017
"Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical TrialsMatthew J Murray, Hannah L Watson, Dawn Ward, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|December 15, 2023
Wilms Tumor With Raised Serum Alpha-Fetoprotein: Highlighting the Need for Novel Circulating BiomarkersRebecca Green, Adeeb Ahmed, Ben Fleming, et al.
Neuro-Oncology Advances|July 10, 2020
Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumorsMatthew J Murray, Thankamma Ajithkumar, Fiona Harris, et al.
British Journal of Cancer|November 3, 2023
Correction: Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruptionShivani Bailey, Marta Ferraresso, Luz Alonso-Crisostomo, et al.
British Journal of Cancer|October 3, 2023
Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruptionShivani Bailey, Marta Ferraresso, Luz Alonso-Crisostomo, et al.
British Journal of Cancer|December 17, 2015
A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumoursMatthew J Murray, Emma Bell, Katie L Raby, et al.
Andrology|October 18, 2022
Small non-coding RNA sequencing reveals global dysregulation of piwi-interacting RNA (piRNA) expression in gonadal malignant germ cell tumoursSean Laidlaw, Luz Alonso-Crisostomo, Shivani Bailey, et al.
Neuro-Oncology|February 26, 2022
Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trialsAdriana Fonseca, Cecile Faure-Conter, Matthew J Murray, et al.
Frontiers in Oncology|July 30, 2024
Acute toxicity of chemotherapy in central nervous system germ cell tumour patients according to ageGilles Palenzuela, Camille Schiffler, Didier Frappaz, et al.
Pageof 6